


| Key | % Net Assets |
|---|---|
| 4.1% | |
| 3.5% | |
| 3.4% | |
| 3.3% | |
| 85.7% |
| Name | % Net Assets |
|---|---|
| SAP | 4.1% |
| Novartis | 3.5% |
| Bureau Veritas | 3.4% |
| Essilor | 3.3% |
| Sanofi | 3.3% |
| Unilever | 3.3% |
| Brenntag | 3.2% |
| Syngenta | 3.1% |
| DnB NOR Bank | 2.9% |
| Vopak | 2.8% |
No asset data available.
| Date | 27-Mar-2025 |
|---|---|
| NAV | 172.90p |
| Currency | GBP |
| Change | -3.10p |
| % | -1.76% |
| YTD change | 16.30p |
| YTD % | 10.41% |
| Fund Inception | 03/10/2003 |
|---|---|
| Fund Manager | Leon Howard-Spink |
| TER | 1.68 (15-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.15 |
You are here: research